Literature DB >> 8622982

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.

A Sanchez1, S G Trappier, B W Mahy, C J Peters, S T Nichol.   

Abstract

In late 1994 and early 1995, Ebola (EBO) virus dramatically reemerged in Africa, causing human disease in the Ivory Coast and Zaire. Analysis of the entire glycoprotein genes of these viruses and those of other EBO virus subtypes has shown that the virion glycoprotein (130 kDa) is encoded in two reading frames, which are linked by transcriptional editing. This editing results in the addition of an extra nontemplated adenosine within a run of seven adenosines near the middle of the coding region. The primary gene product is a smaller (50-70 kDa), nonstructural, secreted glycoprotein, which is produced in large amounts and has an unknown function. Phylogenetic analysis indicates that EBO virus subtypes are genetically diverse and that the recent Ivory Coast isolate represents a new (fourth) subtype of EBO virus. In contrast, the EBO virus isolate from the 1995 outbreak in Kikwit, Zaire, is virtually identical to the virus that caused a similar epidemic in Yambuku, Zaire, almost 20 years earlier. This genetic stability may indicate that EBO viruses have coevolved with their natural reservoirs and do not change appreciably in the wild.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622982      PMCID: PMC39657          DOI: 10.1073/pnas.93.8.3602

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins.

Authors:  P Chambers; C R Pringle; A J Easton
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

2.  Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses.

Authors:  A Sanchez; D Y Pifat; R H Kenyon; C J Peters; J B McCormick; M P Kiley
Journal:  J Gen Virol       Date:  1989-05       Impact factor: 3.891

3.  The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression.

Authors:  A Sanchez; M P Kiley; B P Holloway; J B McCormick; D D Auperin
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

4.  Identification and analysis of Ebola virus messenger RNA.

Authors:  A Sanchez; M P Kiley
Journal:  Virology       Date:  1987-04       Impact factor: 3.616

5.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

6.  Reemergence of Ebola virus in Africa.

Authors:  A Sanchez; T G Ksiazek; P E Rollin; C J Peters; S T Nichol; A S Khan; B W Mahy
Journal:  Emerg Infect Dis       Date:  1995 Jul-Sep       Impact factor: 6.883

7.  Vaccinia-vectored expression of the rubella virus structural proteins and characterization of the E1 and E2 glycosidic linkages.

Authors:  A Sanchez; T K Frey
Journal:  Virology       Date:  1991-08       Impact factor: 3.616

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Preliminary report: isolation of Ebola virus from monkeys imported to USA.

Authors:  P B Jahrling; T W Geisbert; D W Dalgard; E D Johnson; T G Ksiazek; W C Hall; C J Peters
Journal:  Lancet       Date:  1990-03-03       Impact factor: 79.321

10.  Carbohydrate structure of Marburg virus glycoprotein.

Authors:  H Geyer; C Will; H Feldmann; H D Klenk; R Geyer
Journal:  Glycobiology       Date:  1992-08       Impact factor: 4.313

View more
  237 in total

1.  Ebola virus can be effectively neutralized by antibody produced in natural human infection.

Authors:  T Maruyama; L L Rodriguez; P B Jahrling; A Sanchez; A S Khan; S T Nichol; C J Peters; P W Parren; D R Burton
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Sorting of Marburg virus surface protein and virus release take place at opposite surfaces of infected polarized epithelial cells.

Authors:  C Sänger; E Mühlberger; E Ryabchikova; L Kolesnikova; H D Klenk; S Becker
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Non-templated addition of nucleotides to the 3' end of nascent RNA during RNA editing in Physarum.

Authors:  Y W Cheng; L M Visomirski-Robic; J M Gott
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

Review 4.  Emerging viral diseases.

Authors:  S T Nichol; J Arikawa; Y Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

5.  Functional importance of the coiled-coil of the Ebola virus glycoprotein.

Authors:  S Watanabe; A Takada; T Watanabe; H Ito; H Kida; Y Kawaoka
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.

Authors:  Graham Simmons; Rouven J Wool-Lewis; Frédéric Baribaud; Robert C Netter; Paul Bates
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  Ebola virus VP40-induced particle formation and association with the lipid bilayer.

Authors:  L D Jasenosky; G Neumann; I Lukashevich; Y Kawaoka
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

8.  Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity.

Authors:  Gopi S Mohan; Ling Ye; Wenfang Li; Ana Monteiro; Xiaoqian Lin; Bishu Sapkota; Brian P Pollack; Richard W Compans; Chinglai Yang
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

9.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

10.  Evaluation of perceived threat differences posed by filovirus variants.

Authors:  Jens H Kuhn; Lori E Dodd; Victoria Wahl-Jensen; Sheli R Radoshitzky; Sina Bavari; Peter B Jahrling
Journal:  Biosecur Bioterror       Date:  2011-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.